Skip to main content
Amir M. Arain
( out of 103 reviews )

Amir M. Arain, MD, MPH

Languages spoken: Arabic, Urdu, English

Clinical Locations

Clinical Neurosciences Center

Salt Lake City
801-585-7575
  • Dr. Amir M. Arain is a professor and an epileptologist that focuses on treatment of refractory epilepsy. He graduated from Dow Medical College, Karachi and did his Neurology residency and Epilepsy fellowship at Vanderbilt University. There he served on the faculty of Department of Neurology as an epileptologist from 2000-2018. He joined University of Utah in July 2018 and currently serves as chief of Epilepsy division.

    Dr. Arain has been involved in different research projects in epilepsy. He has done several antiepileptic drug trials including levetiracetam, oxcarbazepine, pregabalin, lacosemide, retigabine, brivaracetam, carisbamate, eslicarbazepine and cenobamate. He has published several peer reviewed research articles and has presented data in different scientific meetings. He has trained more than 100 fellows in epilepsy over the years. His interest is in seizure semiology, SUDEP, disparity of care in epilepsy and Geriatric epilepsy.

    Specialties

    Board Certification

    American Board of Clinical Neurophysiology
    American Board of Psychiatry & Neurology (Neurology)
    American Board of Psychiatry & Neurology (Sub: Clinical Neurophysiology)
    American Board of Psychiatry & Neurology (Sub: Epilepsy)

    Patient Rating

    4.6 /5
    ( out of 103 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety.
    Patients are de-identified for confidentiality and patient privacy.

    June 28, 2024
    CLINICAL NEUROSCIENCES CENTER

    It was an exceptional experience. I did not anticipate that he would be as generous with his time, be as thorough, or as understanding. He provided me with confidence in my care and treatment. I trust him.

    June 25, 2024
    CLINICAL NEUROSCIENCES CENTER

    Muy buen doctor siempre contestando las preguntas que hago

    June 20, 2024
    CLINICAL NEUROSCIENCES CENTER

    I have been coming to Dr. Arian for 5 years and really like him he takes his time to talk to you and explain pains things very good so you can understand what he is telling you. I would recommend him to anyone he is amazing

    June 20, 2024
    CLINICAL NEUROSCIENCES CENTER

    Dr. Arain is a spectacular physician and the first neurologist my son has seen who immediately wanted to focus on improving my son's quality of life and seeking surgical alternatives when it became clear medication alone could not control his seizures. I am so grateful for his belief in my son and his focus on giving him more options for a healthy life.

    May 18, 2024
    CLINICAL NEUROSCIENCES CENTER

    He¿s one of the top providing neurologist I think he has help me the through two prior brain surgeries and provided answers while decreasing seizure activity, I am still on the medication, but between all the other neurologist I have seen he has provided the most answers and has helped me the most then I am still with him today I would recommend the neurologist to any epileptic that is seeking help and is looking for answers is a very good neurologist, though he may be a very busy man like I said he has a very top-notch neurologist very good thank you again. I am very blessed to have him.

    May 17, 2024
    CLINICAL NEUROSCIENCES CENTER

    Excellent professional.

    May 16, 2024
    CLINICAL NEUROSCIENCES CENTER

    Always pleased with the care I receive from the doctors at the U.

    May 16, 2024
    CLINICAL NEUROSCIENCES CENTER

    Dr Arain is very friendly and tells you like it is

    May 15, 2024
    CLINICAL NEUROSCIENCES CENTER

    Dr. Arain helped me not have seizures anymore. I will be on medication for the rest of my life, but he makes sure that I continue to stay healthy.

  • Dr. Amir M. Arain is a professor and an epileptologist that focuses on treatment of refractory epilepsy. He graduated from Dow Medical College, Karachi and did his Neurology residency and Epilepsy fellowship at Vanderbilt University. There he served on the faculty of Department of Neurology as an epileptologist from 2000-2018. He joined University of Utah in July 2018 and currently serves as chief of Epilepsy division.

    Dr. Arain has been involved in different research projects in epilepsy. He has done several antiepileptic drug trials including levetiracetam, oxcarbazepine, pregabalin, lacosemide, retigabine, brivaracetam, carisbamate, eslicarbazepine and cenobamate. He has published several peer reviewed research articles and has presented data in different scientific meetings. He has trained more than 100 fellows in epilepsy over the years. His interest is in seizure semiology, SUDEP, disparity of care in epilepsy and Geriatric epilepsy.

    Board Certification and Academic Information

    Academic Departments Neurology -Primary
    Board Certification
    American Board of Clinical Neurophysiology
    American Board of Psychiatry & Neurology (Neurology)
    American Board of Psychiatry & Neurology (Sub: Clinical Neurophysiology)
    American Board of Psychiatry & Neurology (Sub: Epilepsy)

    Education history

    Graduate Training Epidemiology, Biostatistics, Clinical Research Design, etc - Vanderbilt University M.P.H.
    Epilepsy/Neurophysiology - Vanderbilt University Medical Center Clinical Fellow
    Chief Resident Neurology - Vanderbilt University Medical Center Chief Resident
    Neurology - Vanderbilt University Medical Center Resident
    Internship Internal Medicine - McLaren Flint Intern
    Medicine, Surgery - Dow Medical College of the University of Karachi M.B.B.S.

    Selected Publications

    Journal Article

    1. Anderson DN, Charlebois CM, Smith EH, Davis TS, Peters AY, Newman BJ, Arain AM, Wilcox KS, Butson CR, Rolston JD (2023). Closed-loop stimulation in periods with less epileptiform activity drives improved epilepsy outcomes. Brain, 147(2), 521-531. (Read full article)
    2. Campbell JM, Kundu B, Lee JN, Miranda M, Arain A, Taussky P, Grandhi R, Rolston JD (2022). Evaluating the concordance of functional MRI-based language lateralization and Wada testing in epilepsy patients: A single-center analysis. Interv Neuroradiol, 29(5), 599-604. (Read full article)
    3. Simon A, Nguyen D, Newman B, Arain A (2023). Uric Acid Nephropathy Secondary to Generalized Tonic-Clonic Seizures. Neurologist. (Read full article)
    4. Kundu B, Arain A, Davis T, Charlebois CM, Rolston JD (2022). Using chronic recordings from a closed-loop neurostimulation system to capture seizures across multiple thalamic nuclei. Ann Clin Transl Neurol, 10(1), 136-143. (Read full article)
    5. Charlebois CM, Anderson DN, Johnson KA, Philip BJ, Davis TS, Newman BJ, Peters AY, Arain AM, Dorval AD, Rolston JD, Butson CR (2022). Patient-specific structural connectivity informs outcomes of responsive neurostimulation for temporal lobe epilepsy. Epilepsia, 63(8), 2037-2055. (Read full article)
    6. Miranda M, Arias F, Arain A, Newman B, Rolston J, Richards S, Peters A, Pick LH (2022). Neuropsychological evaluation in American Sign Language: A case study of a deaf patient with epilepsy. Epilepsy Behav Rep, 19, 100558. (Read full article)
    7. Brown MG, Sillau S, McDermott D, Ernst LD, Spencer DC, Englot DJ, Gonzlez HFJ, Datta P, Karakis I, Becker D, Rolston JD, Arain A, Rao VR, Doherty M, Urban A, Drees C (2022). Concurrent brain-responsive and vagus nerve stimulation for treatment of drug-resistant focal epilepsy. Epilepsy Behav, 129, 108653. (Read full article)
    8. Anderson DN, Charlebois CM, Smith EH, Arain AM, Davis TS, Rolston JD (2021). Probabilistic comparison of gray and white matter coverage between depth and surface intracranial electrodes in epilepsy. Sci Rep, 11(1), 24155. (Read full article)
    9. Jehi L, Morita-Sherman M, Love TE, Bartolomei F, Bingaman W, Braun K, Busch RM, Duncan J, Hader WJ, Luan G, Rolston JD, Schuele S, Tassi L, Vadera S, Sheikh S, Najm I, Arain A, Bingaman J, Diehl B, de Tisi J, Rados M, Van Eijsden P, Wahby S, Wang X, Wiebe S (2021). Comparative Effectiveness of Stereotactic Electroencephalography Versus Subdural Grids in Epilepsy Surgery. Ann Neurol, 90(6), 927-939. (Read full article)
    10. Frankel MA, Lehmkuhle MJ, Spitz MC, Newman BJ, Richards SV, Arain AM (2021). Wearable Reduced-Channel EEG System for Remote Seizure Monitoring. Front Neurol, 12, 728484. (Read full article)
    11. Scoville JP, Joyce E, Hunsaker J, Reese J, Wilde H, Arain A, Bollo RL, Rolston JD (2020). Stereotactic Electroencephalography Is Associated With Reduced Pain and Opioid Use When Compared with Subdural Grids: A Case Series. Oper Neurosurg (Hagerstown), 21(1), 6-13. (Read full article)
    12. Kundu B, Davis TS, Philip B, Smith EH, Arain A, Peters A, Newman B, Butson CR, Rolston JD (2020). A systematic exploration of parameters affecting evoked intracranial potentials in patients with epilepsy. Brain Stimul, 13(5), 1232-1244. (Read full article)
    13. Bornali Kundu, Tyler S Davis, Brian Philip, Elliot H Smith, Amir Arain, Angela Peters, Blake Newman, Christopher R Butson, John D Rolston (2020). A systematic exploration of parameters affecting evoked intracranial potentials in patients with epilepsy. Brain Stimul, 13(5), 1232-1244.
    14. Zaher N, Haas K, Sonmezturk H, Arain A, Abou-Khalil B (2019). Rhythmic ictal nonclonic hand (RINCH) motions in general EMU patients with focal epilepsy. Epilepsy Behav, 103(Pt A), 106666. (Read full article)
    15. Naoir Zaher, Kevin Haas, Hasan Sonmezturk, Amir Arain, Bassel Abou-Khalil (2019). Rhythmic ictal nonclonic hand (RINCH) motions in general EMU patients with focal epilepsy. Epilepsy Behav, Feb. 2020, 103 pt. A.
    16. Arain AM, Umar A, Rawal P, Azar NJ, Obideen M, Singh P, Al-Kaylani M, Abou-Khalil B (2018). Localization value of ictal turning prone. Seizure, 69, 57-60. (Read full article)
    17. Halford JJ, Westover MB, LaRoche SM, Macken MP, Kutluay E, Edwards JC, Bonilha L, Kalamangalam GP, Ding K, Hopp JL, Arain A, Dawson RA, Martz GU, Wolf BJ, Waters CG, Dean BC (2018). Interictal Epileptiform Discharge Detection in EEG in Different Practice Settings. J Clin Neurophysiol, 35(5), 375-380. (Read full article)
    18. Baker MD, Abou-Khalil BW, Arain A, Tummala P, Azar NJ, Haas KF, Sonmezturk HH (2018). Lacosamide efficacy and tolerability in clinical practice - Post marketing analysis from a single dedicated epilepsy center. Clin Neurol Neurosurg, 171, 179-183. (Read full article)
    19. Sagi V, Kim I, Bhatt AB, Sonmezturk H, Abou-Khalil BW, Arain AM (2017). Generalized paroxysmal fast activity in EEG: An unrecognized finding in genetic generalized epilepsy. Epilepsy Behav, 76, 101-104. (Read full article)